Nurvana Advances Investigational Ischemic Stroke Recovery Research and Explores Strategic University Partnerships
Company highlights early preclinical signals and pursues academic collaborations to strengthen testing and proof-of-concept work
Florida, USA, Oct 08, 2026, ZEX PR WIRE — Nurvana is a healthcare-innovation company developing a proprietary investigational therapy for recovery after ischemic stroke. Today the company reaffirmed its commitment to scientific rigor and transparency. It also announced that it is exploring strategic partnerships with leading universities focused on ischemic stroke research, with the goal of advancing testing and proof-of-concept studies.
Ischemic stroke happens when blood flow to part of the brain is blocked. Many survivors live with lasting problems with movement, memory, thinking, communication, and independence long after emergency care ends. Nurvana’s rese...
